✦ LIBER ✦

Pharmacokinetics of 2-methyl-9-hydroxyellipticinium acetate (NSC-264137) in cancer patients (phase I study)

✍ Scribed by Huertas, Daniel; Droz, Jean-Pierre; Rouesse, Jacques; Amiel, Jean-Louis; Gouyette, Alain

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical study of 9-hydroxy-2N-m

✍ Dodion, P.; Rozencweig, M.; Nicaise, C.; Piccart, M.; Cumps, E.; Crespeigne, N.; 📂 Article 📅 1982 🏛 Elsevier Science ⚖ 382 KB

Metabolism of the anti-tumour drugs N 2

✍ Maftouh, M.; Meunier, G.; Dugue, B.; Monsarrat, B.; Meunier, B.; Paoletti, C. 📂 Article 📅 1983 🏛 Informa plc 🌐 English ⚖ 425 KB

Phase I and pharmacokinetic study of bre

✍ de Forni, M.; Armand, J.-P.; Fontana, X.; Recondo, G.; Domenge, C.; Carde, P.; C 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 575 KB

Phase II study of 9-hydroxy-2-methyl-ell

✍ Anderson, Gerald; Clavel, Michel; Smyth, John; Giaccone, Guiseppe; Gracia, Marco 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 198 KB

Phase I and pharmacokinetic study of amr

✍ Isamu Okamoto; Akinobu Hamada; Yusuke Matsunaga; Ji-ichiro Sasaki; Shinji Fujii; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 242 KB

A phase I and pharmacokinetic study of o

✍ Joseph Chao; Timothy W. Synold; Robert J. Morgan; Charles Kunos; Jeff Longmate; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 259 KB